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Gut microbiota in chicken has long been studied and considered for mostly 
growth performance point of view. And therefore, immunological studies 
regarding gut homeostasis in chicken have been insufficiently achieved. 
Regulatory T cells (Tregs) are a notable subtype of CD4+ T cells playing an 
important role to maintain gut homeostasis in humans and animals. Intestinal 
Tregs are induced by gut microbiota, such as, Clostridium spp. cluster IV and 
XIVa strains, altered Schaedler flora (ASF), or Bacteroides fragilis in mice. 
Although it has been suggested that CD4+CD25+ T cells act as Tregs, there are 
no such studies showing the relationship between gut microbiota and Tregs in 
chickens.  
The first, I established the model for ABX-treated chickens by the 
administration of various concentrations of antibiotic cocktail consisting of 
ampicillin, gentamycin, neomycin, metronidazole, and vancomycin in water. 
Cecal contents from chickens treated with antibiotic cocktail consisting of 100 
g/ml of ampicillin, gentamycin, neomycin and metronidazole, and 50 g/ml 
of vancomycin for 7 days eliminated colony forming unit (CFU) over 99%. 
These chickens treated by certain concentration of antibiotics cocktail (ABX) 
were referred as ‘ABX-treated chickens’. There were no changes on 
physiological traits, for example, weight of body and immune organs (spleen, 
bursa and liver), length of intestine (duodenum, jejunum, ileum and large 
intestine) and the concentration of glucocorticoid in the serum. Furthermore, 
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the population and MHC class II expression on B cells and macrophages in the 
cecal tonsils and spleen were not changed. I concluded that physiological traits, 
B cells and macrophages were not changed in ABX-treated chickens.  
The second, I examined whether subtype of CD4+ T cells was changed in 
ABX-treated chickens. In cecal tonsil, CD4+CD8–CD25+ and 
CD4+CD8+CD25+ T cells were significantly decreased in ABX-treated 
chickens, however these cells in the spleen were not changed. The expression 
of IL-10 and IFN- was significantly decreased in CD4+CD8–CD25+ T cells 
from cecal tonsils of ABX-treated chickens. It was noting that CD4+CD8–
CD25+ and CD4+CD8+CD25+ T cells from ABX-treated chickens did not 
suppress the proliferation of CD4+CD25– T cells. The reduction of CD4+CD8–
CD25+ and CD4+CD8+CD25+ T cells in cecal tonsils from ABX-treated 
chickens expressed high level of CD5hi. Interestingly, the percentage of thymic 
CD4+CD8+CD25+ T cells was not changed in ABX-treated chickens. 
Conclusively, the population and suppressive function of peripheral CD4+CD8–
CD25+ and CD4+CD8+CD25+ T cells decreased in ABX-treated chickens.  
The third, I examined what factors affected the population of CD4+CD8–
CD25+ and CD4+CD8+CD25+ T cells. ABX-treated chickens co-housed with 
wild type chickens recovered the number of gut microbiota, and the proportion 
of CD4+CD8–CD25+ or CD4+CD8+CD25+ T cells in cecal tonsils to similar 
levels as those of wild type chickens. The results further showed that Gram-
positive bacteria appeared to be responsible for the changes of CD4+CD8–
CD25+ or CD4+CD8+CD25+ T cells in cecal tonsils. Feeding acetate, one of the 
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short chain fatty acids, in ABX-treated chickens recovered CD4+CD8–CD25+ T 
cells and CD4+CD8+CD25+ T cells in cecal tonsils. Both butyrate and 
propionate did not show the effect to recover these cells. Interestingly, GPR43 
mRNA level was highly expressed in CD4+CD8–CD25+ T cells. 
Conclusively, my study demonstrated that gut microbiota can regulate the 
population and suppressive function of CD4+CD8–CD25+ or CD4+CD8+CD25+ 
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I. Review of Literature 
 
1. Gut homeostasis 
 
Mouse and human studies suggested that the microbiota continuously 
interact with the intestinal immune system for the balance between pro-
inflammatory and tolerogenic immune responses, called gut homeostasis [1-3]. 
Various immune cells and their products are associated with gut homeostasis 
including forkhead box P3 (Foxp3)+ regulatory T cells (Tregs), T helper 17 
(Th17) cells, IgA+ B cells, innate lymphoid cells (ILCs), transforming growth 
factor (TGF)- and interleukin (IL)-10. Gut homeostasis of chicken has not 
been fully understood and it is assumed to be similar to that of mammals [4].  
 
1.1. Regulatory T cells 
 
Tregs are a subset of CD4+ T cells that exist in peripheral organs and intestine, 
where they help to maintain gut homeostasis. The absence of Tregs results in 
the abnormal expansion of CD4+ T cells expressing commensal bacteria-
specific T cell receptors (TCRs) resulting in intestinal inflammation [5]. The 
development of peripheral Tregs is known to partly depend on the gut 
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microbiota [2, 6]. As shown in Fig. 1, Tregs are induced by specific populations 
of commensal bacteria which comprise Clostridium spp. cluster IV and XIVa 
strains [2], altered Schaedler flora (ASF) [6], or Bacteroides fragilis [3] and/or 
short chain fatty acids (SCFAs) [7] produced as gut microbial product through 
IL-10, TGF- or retinoic acid (RA) expressing antigen presenting cells (APCs), 
such as, CD103+ dendritic cells (DCs) and CD11b+CD11c– macrophages. 
 
Figure 1. Induction of Tregs by host cells, gut microbiota and their 
products. Tregs are known to be induced by specific populations of commensal 
bacteria together with their product, SCFAs and PSA, through IL-10, TGF- or 




Besides Foxp3+ Tregs, CD4+Foxp3– type 1 regulatory T (Tr1) cells, one of 
Treg subsets, could contribute to gut homeostasis by suppressing inflammatory 
condition. In SCID mice with inflammatory bowel disease (IBD), antigen 
specific Tr1 cells (pre-induced in vitro with IL-10) prevented to the progression 
of colitis [8]. It has been suggested that Bifidobacterium breve and B. longum, 
as probiotics, induced Tr1 cells in mouse and alleviated the development of 
intestinal inflammation [9]. CD4+CD25+ T cells of chicken are known as Tregs 
[10], which are absent of Foxp3 gene [11, 12], unlike their mammalian 
counterpart. Furthermore, chicken CD4+CD25+ T cells migrated preferentially 
cecal tonsils rather than spleen and lung [13]. Chicken Tregs are not fully 
investigated, for example, intrinsic and extrinsic factors conditions to induce 
Tregs. 
 
1.2. T helper 17 cells 
 
Th17 cells are one of CD4+ T cell lineages, producing IL-17A, IL-17F and 
IL-22, which have a role for host defense and development of autoimmune 
disease in human and mouse [14]. Intestinal Th17 cells are significantly 
reduced in antibiotic-treated or germ-free mice [1, 15-18], suggesting that the 
microbiota play a crucial role to develop Th17 cells in gut. Segmented 
filamentous bacteria (SFB), one of Clostridia-related bacteria, induces the 
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generation of Th17 cells [1, 16, 17]. SFB stimulates the host epithelium to 
upregulate serum amyloid A protein (SAA) production, which is known to 
promote IL-6 and IL-23 from CD11c+ lamina propria (LP) DCs [1]. ATP 
produced by gut microbiota, but not much of pathogens, for instance, 
Salmonella typhimurium which secreted ATP lesser than gut microbiota 
resulting in induction of Th1 cells, promotes LP CD70hiCD11clow cells to 
develop Th17 cells [15]. Regenerating islet-derived protein 3 g (RegIIIg), as a 
C‑type lectin antimicrobial peptide, from Th17 cells prevents the intestinal 
infection by pathogens including Citrobacter rodentium and Listeria 
monocytogenes [19-21]. In chicken studies, IL-17 is assumed as Th17 response, 
simply because anti-chicken IL-17 antibody to measure the cells secreting IL-
17 directly is not available. Salmonella enterica serovar Enteritidis infection in 
chicken induced IL-17 in ceca [22]. It has been suggested that IL-17 was 
increased in chicken infected with Eimeria tenella, a protozoan parasite [23, 
24]. The role of Th17 cells in the gut of chicken has yet to be fully understood. 
 
1.3. Immunoglobulin A  
 
The relationship between gut microbiota and gut-specific B cell responses, 
for instance, immunoglobulin A (IgA) secretion, is closely associated. IgA is an 
active component involving host protection and a major class of 
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immunoglobulin in the intestine. IgA exists as a polymeric IgA in the intestinal 
lumen [25]. Secreted IgA (SIgA) can recognize commensal bacteria and soluble 
antigens to inhibit penetration into the lamina propria [25]. IgA regulates the 
composition of the gut microbiota [26, 27]. Activation-induced cytidine 
deaminase, which is known to be essential enzyme for class switching, 
deficiency mice showed increase anaerobic bacteria, including 
Peptostreptococcus, Bacteroidacease, Eubacterium and Bifidobacterium in 
small intestine, whereas cecum microbiota was not changed [28]. Furthermore, 
gut microbiota regulates IgA production, as the number of IgA-producing cells 
in the intestine, for example, is decreased significantly in germ-free mouse [25]. 
Commensal bacteria induces various effector molecules, such as tumor necrosis 
factor (TNF), inducible nitric oxide synthase (iNOS), B cell activating factor 
(BAFF) and a proliferation-inducing ligand (APRIL) that are involved in the 
induction of IgA+ B cells in lamina propria [29, 30]. It is probable that gut 
microbiota stimulates DCs in lamina propria to induce IgA+ B cells, and in 
return, SIgA regulates the function and composition of the gut microbiota to 
maintain gut homeostasis. In chicken, IgA expression of ileum, ceca and cecal 
tonsils was burst at 7 days post hatching [31]. Probiotics mixture, consisting of 
Lactobacillus acidophilus, Bifidobacterium bifidum, and Streptococcus faecalis, 
induced natural IgA from intestinal contents reacting tetanus toxoid and 
Clostridium perfringens alpha-toxin [32]. However, there is no molecular 




1.4. Innate lymphoid cells 
 
ILCs are known as immune cells involved in innate immune responses [33, 
34] in human and mouse studies. It has been suggested that gut microbiota is 
required for the differentiation of ILCs and the production of IL-22 [35, 36]. In 
other study, gut microbiota suppressed IL-22 production by RORγt+ ILCs [37]. 
A role of IL-22 in the gut is to promote antimicrobial peptide production by 
intestinal epithelial cells. IL-22 induces the expression of the C-type lectin 
antimicrobial peptides, for example, RegIII, which protect the host from the 
infection of pathogens, for example, enterohemorrhagic Escherichia coli 
(EHEC) and enteropathogenic E. coli (EPEC) and C. rodentium [19]. RegIII 
limited the number of surface-associated Gram-positive bacteria, Firmicutes 
phylum (Eubacterium rectale, and SFB), and activation of adaptive immunity, 
for instance, IgA and IFN-+ cells [21]. Conclusively, ILCs regulate not only 
both commensal and harmful bacteria but also host immunity in the gut. There 






2. Gut microbiota in chicken 
 
2.1. Intestine  
 
  The intestine is important in converting the feed into the nutrients for animals’ 
maintenance and growth. Digestive tract of chicken is composed of beak/mouth, 
esophagus, crop, proventriculus, gizzard, small intestine, ceca, large intestine 
and cloaca. During the digestion, morphology and chemical composition of 
feed change as they passing through several organs. Since chicken does not 
have teeth, they pick up feed with beak and it enters the mouth without chewing. 
Crop, an out-pocketing of the esophagus, is located in the neck region and stores 
feed and water [38]. When crop is empty, or near empty, hunger signal transmit 
to the brain [39]. Very little digestion occurs in crop by amylase secreted in 
mouth [40].  
Proventriculus plays as the true stomach and begins to digest feed with 
hydrochloric acid and pepsin [41]. However, feed is not yet ground at this point. 
Gizzard is a unique digestive organ in chicken. It is referred to as ‘mechanical 
stomach’ since strong muscles of gizzard as acts like the bird’s teeth [42]. 
Furthermore, feed is grinding, mixing, and mashing with digestive enzymes in 
gizzard [41].  
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Small intestine in chicken is consisted of the duodenum, jejunum and ileum 
similar to that of a mammal. Duodenum secrets digestive enzymes and 
bicarbonate to counter the hydrochloric acid [43]. Digestive enzymes produced 
by the pancreas are primarily involved in protein digestion. Digestion of lipids 
and absorption of fat-soluble vitamins, such as, vitamins A, D, E and K in here 
occurs with bile [44]. Nutrients are absorbed mainly in the jejunum and ileum.  
Ceca are two blind pouches located and a joint point of the small and large 
intestine. Water in fecal material is reabsorbed and fermentation of indigestible 
materials at here. It is known that the fermentation produces short fatty acids 
and vitamin B [45, 46]. Large intestine in chicken is much shorter than the small 
intestine in chicken. The last of water re-absorption occurs in here. In cloaca, 
feces are mixed with urine from urates.  
 
  2.2. Establishment of gut microbiota  
 
Microorganisms in animal gut has evolved with host [47]. Microorganisms 
are abundant in the colon and ceca of chicken [48]. Domestic birds, including 
chicken, duck, and turkey, have about 1 × 1011 cells/g in ceca [49, 50].  
The chicks are initially exposed to microbes from the surrounding 
environment. Therefore, the early stage of the post hatching period would be 
critical for the formation of gut microbial community. The density of gut 
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microbiota in chicken increased rapidly within 24 h post hatching [51, 52]. 
Aerobes such as Enterobacteriaceae, Lactobacillus, and Streptococcus 
colonized initially in small intestine show a positive oxidation at hatching [53, 
54]. Then, oxygen consumption by aerobes causes more anaerobic conditions 
in lower gut environment, which facilitates growth and colonization of the 
obligate anaerobes [49, 55, 56].  
Ceca contain a more diverse community of gut microbiota, including 
Bacteroides, Bifidobacterium, Clostridium, Enterococcus, Escherichia, 
Fusobacterium, Lactobacillus, Streptococcus and Campylobacter in chicken 
[56-58]. Density of gut microbiota increases throughout the digestive tract, for 
example, duodenum, ileum and ceca contain 103–105, 108–109, <1012 colony 
forming unit (CFU) gram-1 of digesta by microscope-counts, respectively [56, 
58].  
 
2.3. Gut microbiota on growth performance  
 
The role of gut microbiota in chicken has long been interested for research 
scientists, industry and the field, because of its impact on growth performance. 
Probiotics have several positive effects in chicken, (1) improvement of weight 
gain and feed utilization, (2) decrease mortality through preventing enteric 
pathogens (3) to attach and colonize in intestine [59, 60]. Non-degradable 
10 
 
complex carbohydrates from diet in the small intestine, such as non-starch 
polysaccharides and resistant starch, are the main sources of carbon and energy 
for the commensal bacteria [61]. The metabolites are derived from fermentation 
by intestinal bacteria, which are consumed as the energy source for host [62]. 
For example, SCFAs, which are the metabolites by anaerobic microbes utilizing 
carbohydrates, are considerable energy source in animal [63]. Several pathways 
associated with production of SCFAs were detected in a meta-genomic analysis 
of cecal microbiota in chicken [64]. SCFAs from fermentation of non-
hydrolysable oligo- and polysaccharides feeding may provide extra energy and 
a better feed conversion ratio in chicken.  
 
2.4. Effects of gut microbiota on immunological aspect  
 
Gut immune homeostasis in chicken, although seemingly similar to that of 
mammals, has not yet been fully understood. However, there are some studies 
about the relationship between gut microbiota and immune system in chicken. 
The complexity of gut microbiota impacts the repertoire of TCR in the gut [65] 
and the kinetics on the expression of immune-associated genes during the 
maturation of gut immune system [66]. It has been suggested that gut 
microbiota also indirectly affects the development of B cells in the bursa. When 
the bursal duct is ligated during embryonic development to preclude the normal 
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traffic of gut-derived molecules into the bursa, cortico-medullary structure in 
bursal follicle fails to develop normally after hatching [67, 68]. The mechanism 
of the phenomenon is explained that these gut-derived molecules, probably and 
mostly bacterial mitogens, could directly induce maturation and proliferation 
of bursal B cells [69, 70], or indirectly stromal cells to produce cytokines, 
perhaps via Toll-like receptor (TLR) signaling, for B cell development [71].  
 
2.5. Cecal tonsils 
 
The gut-associated lymphoid tissue (GALT) consists of multiple lymphoid 
follicles and these are made up of cecal tonsils (CTs), Peyer’s patches (PPs), 
the bursa of Fabricius, Meckel’s diverticulum located along the digestive tract 
in chicken [72]. Especially, CTs are located on the entrance of each cecum, 
which consist of a pair of fingerlike pockets located in end of small intestine. 
CTs are histologically [73, 74] and immunologically [75] as secondary 
lymphoid tissue, similar to the spleen. CTs consist of a cryptosporidians, diffuse 
lymphoid follicles and germinal centers [76]. Considering cellular and 
morphological features, a role in antigen sampling of CTs could be similar to 
mammalian PPs [72, 77]. Within organized lymphoid structures, such as CTs, 
CD4+  T cells and B cells exist [78, 79], whereas  T cells predominate in 
dispersed areas, such as the epithelium and LP [80]. 
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The development of CTs during embryogenesis has not been described in 
detail. CTs are appeared at near hatching [76, 81], unlike lymphoid cells 
infiltrate at presumptive sites of PPs [72]. During embryogenesis, clusters of 
MHC class II+ cells, a few scattered Bu-1+ cells and IgM+ cells were observed 
at E13. At E17, MHC class II+ cells were widely and densely expended, and 
Bu-1+ cells and IgM+ cells are increased more than those at E13 [82]. It suggests 
that MHC class II+ cells, presumably antigen presenting cells including 






Tregs are a subtype of CD4+ T cells, known to play an important role in 
maintaining gut immune homeostasis since the gastrointestinal tract is 
constantly exposed to inflammatory condition by a huge microbial components 
[84]. In mouse and human, Foxp3 is the master transcription factor for Tregs 
[8, 85]. Common surface molecule and cytokines as makers for Tregs are high 
expression of CD25 (IL-2 receptor ), and IL-10 and TGF-, respectively [86]. 
Non-Foxp3 Tregs, also called Tr1 cells [87], induced by chronic activation of 
CD4+ T cells with antigen and IL-10 [8] are also reported. Although the master 
transcription factor is unknown for Tr1 cells yet, unique features of cytokines 
are suggested as IL-10++, TGF-+, interferon (IFN)-+, IL-5+, IL-4– and IL-2low/– 
[8, 88]. CD4+CD25+ T cells in chicken has been reported as Tregs [10], 
although no Foxp3 orthologue gene exists [11].  
Certain gut microbiota, including Clostridium spp. cluster IV and XIVa 
strains, ASF, or Bacteroides fragilis, are known to induce Foxp3+ Tregs in mice 
and human [2, 3]. These bacteria alleviate the symptom of IBD by inducing 
Tregs [2, 3, 6]. However, no such studies on the relationship between gut 
microbiota and Tregs are reported in chicken.  
Gut immune homeostasis is largely regulated by microbiota in not only a 
direct [3] but also indirect manner. Induction [2] and function [3] of Tregs are 
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affected by gut microbiota related factors, such as SCFAs [89-91] including 
acetate (C2), propionate (C3), and butyrate (C4), which are generated 
especially by Firmicutes and Bacteroidetes, after fermenting undigested 
carbohydrates [84]. It has been shown that acetate, propionate and butyrate exist 
in 3:1:1 ratio, respectively at 50-150 mM in colon of mouse [92], whereas 50-
70 mM of acetate, 5-30 mM of butyrate and 5-10 mM of propionate are 
contained in chicken ceca [93-95].  
It has been shown in mouse experiments that several G protein coupled 
receptors (GPRs) on immune and non-immune cells recognize SCFAs [96, 97]. 
Activation of GPR43 using SCFAs promotes the number and function of IL-
10+Foxp3+ Tregs, and propionate directly increases Foxp3 expression and IL-
10 production [91]. GPR109a, expressed on colonic epithelial cells, DCs and 
macrophages [98], is known to be activated by butyrate. 
IL-10 and RA produced by mostly antigen presenting cells treated with 
SCFAs [99] could induce the differentiation of naïve T cells into Foxp3+ Tregs 
and Tr1 cells [99]. SCFAs are also known to act as a histone deacetylase 
(HDAC) inhibitor. For instance, butyrate enhances acetylation at histone H3 
lysine 27 (H3K27) of the Foxp3 promoter causing the differentiation of naïve 
T cells into Tregs [89]. Acetate, on the other hand, induces the acetylation of 
p70 S6 kinase and phosphorylation rS6, resulted in Tr1 cell induction [100]. 
There are not only a very few studies on immunological effects of SCFAs in 
chicken but also no reports about the factors regulating gut homeostasis.  
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Germ-free mouse model has been a critical tool to carry out the research on 
immune homeostasis in the mucosal tissues as well as peripheral organs for 
decades [101-103]. Gut immune balance is the result of interaction among 
various immune cells including Tregs, Th17 cells, IgA secreting B cells, and 
innate immune cells [103]. In indigenous germ-free mice, peripheral Tregs 
(pTregs) are scarce in the lamina propria of the intestine [2, 104]. Antibiotics 
cocktail (ABX) treatment is an alternative way to make an intestinal germ-free 
animal. ABX-treated mice showed closely resembling indigenous germ-free 
mice in terms of immunological changes in not only the gut but also peripheral 
organs [105-107]. The presence of intestinal Th17 cells is dramatically reduced 
in ABX-treated mice [16]. Although Foxp3+ Tregs are still detectable, they are 
significantly decreased in colonic lamina propria [2]. Unfortunately, there is no 
report, at the best of my knowledge, on immunological researches in germ-free 
or gut microbiota-free chicken model.  
In the present study, the model for studying gut immune homeostasis in 
chicken treated with ABX was established. The main goal of the study was to 
(1) examine the changes in population and function of immune cells in ABX-





III. Materials and Methods 
 
  1) Experimental animal and ABX treatment 
 
Fertile eggs of White Leghorn were provided by Animal Farm, Seoul 
National University, Pyeong-Chang, Korea. Fertile eggs were incubated at 
37.5-38°C incubator (Rcom, Korea) for 21d. The condition of cage sustained 
28-30°C and filte 
 
red air. Care room maintained 23-25°C, 20-40% of humidity and positive 
pressure. The experiment was approved by Institutional Animal Care and Use 
Committee of Seoul National University (IACUC No., SNU-150327-2). 
Crumble feed was supported by SeoulFeed company and sterilized by -
radiation by GREENPIA TECHNOLOGY company. For antibiotics treated 
group, chickens at hatching were treated with various concentrations of 
antibiotics in drinking water ad libitum for 7 days. I defined dilution factor (DF) 
1 as an antibiotics containing ampicillin, gentamycin, neomycin (all from 
Sigma-Aldrich, St. Louis, MO) and metronidazole (Abcam, Cambridge, MA) 
for 1 mg/ml each, and vancomycin (Sigma-Aldrich) for 0.5 mg/ml. DFs were 
tested 1:1, 1:2, 1:10, and 1:20. As control (Con) group. ABX-treated chickens 
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were referred by treatment of 1:10 diluted antibiotics for 1-3 weeks. 
 
2) Measurement of colony forming unit  
 
Cecal contents from chickens treated with ABX were dissolved in PBS to 
adjust at 1 mg/ml. Dissolved cecal contents from Con group were diluted in 
100-1000 times with PBS while those from ABX-treated group were used 
without dilution. All dissolved cecal contents were spread on Brain Heart 
Infusion (BHI) agar media (BD Biosciences, San Jose, CA) and then incubated 
at 37°C for 12 hr. CFU was determined by counting the number of colony. 
 
3) Examination of physiological changes in ABX-treated chickens 
 
Body weight changes were monitored in chickens every day for 7 days. At 
the end of the experiment, major immune organs (liver, spleen and bursa) were 
taken and briefly semi-dried by tapping on paper towel, and the weight was 
examined. Length of intestine was segmented to jejunum (J), duodenum and 
ileum (D+I), Ceca (C) and large intestine (L), and measured with millimeter 
scale. Blood samples from a wing vein were taken at 7 days after the ABX 
treatment. Amount of glucocorticoid in serum, which was obtained by 
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centrifugation at 1,000 × g at 4°C for 20 min, was measured by chicken 
glucocorticoid ELISA kit (MyBioSource, San Diego, CA). In brief, 50 l of 
serum per well, diluted to 1:50 (pre-determined, data not shown), along with 
standard samples, was added to a 96-well microplate pre-coated with 
glucocorticoid specific antibodies. After the wash with PBS, 50 μl of secondary 
antibody, conjugated with HRP, was added into each well, and color was 
developed by the addition of 90 μl of tetramethylbenzidine. The reaction was 
stopped by the addition of 50 μl of stop solution. Absorbance was measured at 
450 nm using an ELISA microplate reader (Molecular Device, Sunnyvale, CA) 
and the amount of glucocorticoid was calculated from the standard curve. 
 
4) Flow cytometric analysis for immune cells 
 
Chunked spleen or longitudinally cut cecal tonsils after wash were minced 
with the flat end of a 3 ml syringe plunger through a 40 m cell strainer (BD 
Biosciences, San Jose, CA) into a 50 ml conical tube (SPL, Pocheon, Korea). 
In order to purify immune cells, red blood cells were lysed using ACK buffer 
(BD Biosciences) for 3 min at room temperature, and then washed.  
For examination of B cells and macrophages, anti-chicken MHC class II-
FITC (clone 2G11), Monocyte/Macrophage-PE (clone KUL01), and Bu-1-
Alexa Flour 647 (AV20) (all from Southern Biotec, Birmingham, AL) were 
19 
 
used. In order to examine CD4+ subtype T cells, anti-chicken CD4-FITC (clone 
CT-4), CD8 -PE (clone CT-8), CD5-biotin (clone 2-191) (all from Southern 
Biotec) and CD25-Alexa Fluor 647 (clone 13504; AbD Serotec, Puchheim, 
Germany), and Brilliant Violet 605 streptavidin (BioLegend, San Diego, CA) 
were used.  
Flow cytometric data, acquired by flow cytometry (FACS Canto II, BD 
Biosciences), were analyzed with FlowJo software (Tree Star, San Carlos, CA). 
Total cell number was determined by automatic cell counter TC10 (Bio-Rad, 
Hercules, CA). Each number of immune cells was calculated from total cell 
number and the proportion of immune cells.  
 
5) Measurement of mRNA level using RT-qPCR 
 
CD4+ subtype T cells (CD4+CD8–CD25–, CD4+CD8–CD25+, 
CD4+CD8+CD25– and CD4+CD8+CD25+) B cells (Bu-1+) and APCs (KUL01+, 
MHC class II+Bu-1–KUL01–) were sorted by using ARIAII FACS sorter (BD 
Biosciences). Total RNA of each CD4+ subtype T cells was extracted by 
miRNeasy Micro Kit (QIAGEN, Hilden, Germany). The concentration of total 
RNA was quantified with NanoDrop (Amersham Biosciences, Piscataway, NJ) 
at A260. Subsequently, 100 ng of purified RNA was reverse transcribed to 
cDNA using M-MLV Reverse Transcriptase (Invitrogen, Carlsbad, CA) 
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according to the manufacturer’s instruction.    
The real-time quantitative PCR was performed on cDNA using a StepOne 
Plus real-time PCR system (Applied Biosystems, Foster City, CA). SYBR 
green PCR master Mix was used according to manufacturer’s specification 
(Applied Biosystems). The PCR reaction was carried out in a 96-well reaction 
plate with 10 l SYBR PCR master mix, 0.5 l per primer (2 pM), 1-2 l cDNA 
template and 7-8 l nuclease-free water. Each reaction involved a pre-
incubation at 95 °C for 10 min, followed by 45 thermal cycles at 95 °C for 15 
s, 55 °C for 30 s, and elongation at 72 °C for 30 s. Relative quantification of 
target genes was calculated using the 2-Δ ΔCt method.  
Target gene expression was normalized to -actin mRNA level. Primers for 
IL-10 (forward: 3’-AGCTGACGGTGGACCTATTATT-5’, reverse: 3’-
GGCTTTGCGCTGGATTC-5’), IFN- (F: 3’-CGGGAGCTGAGGGTGAA-5’, 
R: 3’-GTGAAGAAGCGGTGACAGC-5’), Ahr (F: 3’- 
CAGGTCCCTGAAAACCTTGACT-5’, R: 3’- 
ACGGCACCTGCATAACATGTT-5’), Maf (F: 3’- 
CCCCGTTACCTGAGGTCAGA-5’, R: 3’- 
GTCTTCGTGCCAGAACGTTGT-5’), G-coupled protein receptor 43 (F: 3’-
CTCTTTATGGCTGCCCTCAG-5’, R: 3’- GTAGCCCAGGCTTGGTTGG-5’) 
and -actin (F: 3’-CAACACAGTGCTGTCTGGTGGTA-5’, R: 3’-
ATCGTACTCCTGCTTGCTGATCC-5’) were synthesized from Bioneer Inc. 




6) Changes on the subtype of CD4+ T cells treated with antibiotics 
in vitro 
 
Spleens from 2-3 weeks old-chickens were taken and single cells were 
produced. Splenocytes (1 × 105 cells/well) in a 96-well culture plate (Nunc, 
Roskilde, Denmark) were treated with 100 g/ml of ampicillin (A), gentamycin 
(G), metronidazole (M), neomycin (N) and 50 g/ml of vancomycin (V) for 24 
h. Change of CD4+ subtype T cells was analyzed by flow cytometry with anti-
chicken CD4-FITC, CD8-PE and CD25-Alexa Fluor 647. Total cell numbers 
were determined by automatic cell counter TC10. Cell number of each CD4+ 
subtype T cells was calculated from total cell number and the proportion of 
CD4+ subtype T cells was analyzed by using FlowJo software. 
 
7) T cell suppression assay  
 
  Splenocytes from Con and ABX group were stained with anti-chicken 
CD4 antibody followed by the incubation with anti-mouse IgG bead (Miltenyi 
Biotec, Auburn, CA) for 30 min. CD4+ T cells were sorted by MACS magnetic 
bead system (Miltenyi Biotec). CD4+ T cells were stained with 1 M 
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CellTrace™ Violet (CTV) dye (Invitrogen, Carlsbad, CA) for 20 min at 37°C, 
and then washed 3 times with pre-warm complete RPMI. CD4+ T cells stained 
with CTV were cultured with anti-chicken CD3 and CD28 antibodies for 3 d. 
The cells were stained with anti-chicken CD4-FITC, CD8-PE and CD25-
Alexa Fluor 647 and the proliferation of CD4+CD25– T cells was determined 
by flow cytometry and FlowJo software. 
 
8) Co-housing experiment 
 
Co-housing experiment was performed for 7 days at the end of ABX 
treatment. Cecal contents and cecal tonsils were taken at 6 h, 1, 3, 5 and 7 days 
after co-housing. Cecal contents were dissolved at 1 mg/ml. Dissolved cecal 
contents from Con and ABX group were diluted by 10-1000 times to adjust into 
proper range of colony numbers (data not shown). Then, the contents were 
spread on BHI agar media and incubated at 37°C for 12 hr. CFU was determined 
by counting the number of colony. For analysis for CD4+ subtype T cells, 
longitudinally cut cecal tonsils were processed into single cells. Anti-chicken 
CD4-FITC, CD8-PE and CD25-Alexa Flour 647 were used for examination 
of CD4+ subtype T cells. All flow cytometric data, acquired by flow cytometry, 
were analyzed with FlowJo software. A total cell number was determined by 
automatic cell counter TC10. Each cell number of CD4+ subtype T cells was 
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calculated with total cell number and the percentage of CD4+ subtype T cells. 
 
9) The elimination of Gram positive and negative bacteria 
 
Chickens at hatching were treated with vancomycin (100 g/ml; Van) for the 
removal of Gram positive bacteria or polymyxin B (10 g/ml; PolyB) for Gram 
negative bacteria for 7 days. CFU of cecal contents (1 mg/ml) was measured. 
Gram staining was performed by using the kit (BD Biosciences). 
  
10) Administration of short chain fatty acids  
 
Chickens at hatching were fed with a diet containing SCFAs, acetate (50 
mM), butyrate (30 mM), and propionate (10 mM) (concentration pre-
determined, data not shown), and ABX as a positive control for 7 days. Cecal 
tonsils were taken and subtype of CD4+ T cells was analyzed with anti-chicken 
CD4-FITC, CD8a-PE and CD25-Alexa 647. All flow cytometric data were 
analyzed with FlowJo software.  
 




Using SAS 9.3, statistical differences were determined using T-test and one-








1) Elimination of gut microbiota in chicken   
 
Elimination of gut microbiota in chickens administered with a various 
concentration of ABX in drinking water [108] containing ampicillin, 
gentamycin, metronidazole, neomycin, and vancomycin (Table 1) ad libitum 
for 7 days was examined. Colony from cecal tonsils of chicken treated with 
ABX (1:10) was not observed (Fig. 2). The result demonstrated that gut 
microbiota of chickens treated with ABX at 1:10 were eliminated. Therefore, 





Figure 2. Elimination of gut microbiota in chickens treated with antibiotics. 
Chickens were treated with distilled water (control, Con) or cocktail of 
antibiotics (ABX, 1:10) for 7 days. Nine ceca were taken and cecal contents 
diluted with autoclaved distilled water were plated on BHI agar plate for 12 hr 
at 37C°. (A) CFU was determined by counting the number of colonies on the 




Table 1. Elimination of gut microbiota in chickens administered with 
various concentration of antibiotics in drinking water for 7 days. 
DF A G M N V Unit Elimination of 
microbes (%) 








1:10 100 100 100 100 50 99 > 
1:20 50 50 50 50 25 97 > 






  2) Verification of physiological alteration in ABX-treated chickens 
 
It is critical that no side effects or physiologic changes are observed after the 
elimination of gut microbiota in chickens. No significant differences on body 
weight, and the length of distinct regions of small intestine (duodenum, jejunum 
and ileum) and large intestine (Fig. 3A-B) were observed. Amount of 
glucocorticoid in serum, as a stress marker, was not changed (Fig. 3C). 
Furthermore, the weight of major organs including spleen, bursa and liver was 
not altered (Fig. 3D). Taken together, ABX treatment in chicken model in the 





Figure 3. No physiologic changes in ABX-treated chickens. ABX in drinking 
water was treated to chickens at hatching for 7 days. (A) Body weight was 
measured daily. (B) The length of intestine (D: duodenum, J: jejunum, I: ileum), 
(C) amount of glucocorticoid by ELISA and (D) the weight of major immune 




3) Change of B cells and macrophages in ABX-treated chickens 
 
I examined whether the elimination of gut microbiota affects the population 
of B cells (MHC2+Bu-1+ cells) and macrophages (KUL01+ cells) in cecal 
tonsils and spleen in chickens. No significant changes on the percentage and 
absolute number of B cells and macrophages in cecal tonsils (Fig. 4A-D) and 
spleen (Fig. 4E-H) were observed. Furthermore, MHC class II (MHC2) 
expression on B cells and macrophages in cecal tonsils (Fig. 4I and J) and 
spleen (Fig. 4K and L) was not significantly changed. Taken together, 
population and expression of MHC2 of B cells and macrophages did not alter 





Figure 4. No changes of B cells and macrophages in cecal tonsils and spleen 
in ABX-treated chickens. Chickens, treated with antibiotics for 7 days, were 
sacrificed, and then (A-D and I, J) cecal tonsils and (E-H and K, L) spleen were 
taken. Single cells produced from each organ were stained with anti-chicken 
MHC class II (MHC2), KUL01 (for macrophages), and Bu-1 (for B cells) 
antibodies. The percentage of (A and E) B cells and (B and F) macrophages, 
and absolute number of (C and G) B cells and (D and H) macrophages was 
calculated from their percentages. MFI of MHC2 on (I and K) B cells and (J 







4) Change of CD4+ T cells in ABX-treated chickens 
 
To examine the percentage and absolute number of CD4+ subtype T cells in 
cecal tonsils, flow cytometry analysis after the staining of the cells with anti-
chicken TCR, CD3, CD4, CD8, and CD25 antibodies was performed. 
CD3+TCR– cells were pre-gated, and then, CD4+ T cells were divided into 
CD4+CD8– and CD4+CD8+ T cells. Finally, CD25+ cells were analyzed (Fig. 5). 
Total cell number of cecal tonsils showed no significant changes in ABX-
treated chickens (ABX) when compared to control (Fig. 6A). Furthermore, 
there were no changes on  T cells (Fig. 6B and G), and CD4+CD8– (Fig. 6C 
and H) and CD4+CD8+ (Fig. 6D and I) T cells. Interestingly, in CD4+CD8–
CD25+ (Fig. 6E and J) and CD4+CD8+CD25+ T cells (Fig. 6F and K) T cells 
from cecal tonsils were significantly reduced in ABX compared with those of 
control (Con). Interestingly, however, no significant changes on CD4+CD8–






Figure 5. Gating strategy to analyze subtype of CD4+ T cells. Chickens at 
hatching were given water containing antibiotics for 7 days and cecal tonsils 
were taken. Single cells produced from cecal tonsils were, then, stained with 
anti-chicken TCR, CD3, CD4, CD8, and CD25 antibodies. CD3+TCR– 
cells gated were regarded as T cells, and then, CD4+CD8–CD25+ and 





Figure 6. CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells were reduced in 
cecal tonsils from ABX-treated chickens. Chickens at hatching were given 
water containing antibiotics for 7 days and cecal tonsils were taken. Single cells 
from cecal tonsils were, then, stained with anti-chicken TCR, CD3, CD4, 
CD8, and CD25 antibodies. (A) Total number of cells in cecal tonsils is shown. 
The percentage of (B) CD3+TCR– cells, (C) CD4+CD8– T cells, (D) 
CD4+CD8+ T cells, (E) CD4+CD8–CD25+ and (F) CD4+CD8+CD25+ T cells, 
and absolute number of (G) CD3+TCR– T cells, (H) CD4+CD8– T cells, (I) 
CD4+CD8+ T cells, (J) CD4+CD8–CD25+ and (K) CD4+CD8+CD25+ T cells was 
calculated with the percentage of these cells. Significant differences were 




Figure 7. CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells were not changed 
in spleen from ABX-treated chickens. Chickens at hatching were given water 
containing antibiotics for 7 days and spleens were taken. Single cells from 
spleens were, then, stained with anti-chicken CD4, CD8, and CD25 antibodies. 
(A) Total number of cells in spleen is shown. The percentage of (B) CD4+CD8– 
T cells, (C) CD4+CD8+ T cells, (D) CD4+CD8–CD25+ and (E) 
CD4+CD8+CD25+ T cells, and absolute number of (F) CD4+CD8– T cells, (G) 
CD4+CD8+ T cells, (H) CD4+CD8–CD25+ and (I) CD4+CD8+CD25+ T cells was 




5) Change of IL-10 and IFN- from subtype of CD4+ T cells in ABX-
treated chickens 
 
Chicken CD4+CD25+ T cells expressed high IL-10 and played a role as Tregs 
[10]. I examined whether the elimination of gut microbiota affects mRNA 
expression of cytokines in subset of CD4+ T cells. Interestingly, both IL-10 (Fig. 
8A) and IFN- (Fig. 8B) mRNA in CD4+CD8–CD25+ T cells were significantly 





Figure 8. Expression of IL-10 and IFN-γ mRNA among CD4+ T cell subsets 
in cecal tonsils from ABX-treated chickens. Chickens at hatching were given 
water containing antibiotics for 7 days and cecal tonsils were taken. Single cells 
from cecal tonsils were, then, stained with anti-chicken CD4, CD8 and CD25 
antibodies. Each subset of CD4+ T cells was sorted by using ARIA II FACS 
sorter. The mRNA was extracted from each subset and the level of (A) IL-10 
and (B) IFN- was determined by RT-qPCR. Relative quantification of target 
genes was calculated using the 2–ΔΔCt method and normalized to actin mRNA 
level. Significant differences were shown as asterisks between Con and ABX 





6) Direct effect of antibiotics on the change of CD4+CD8–CD25+ 
and CD4+CD8+CD25+ T cells  
 
In order to examine the possibility for the change of these T cells by direct 
effect of antibiotics, I performed in vitro experiment where pre-determined 
(data not shown) each antibiotic or combination was treated to splenocytes for 
24 h. There were no significant differences on the cell number (Fig. 9A) and 
the proportion of these cells (Fig. 9B) when compared with control. These 
results suggested that the reduction of CD4+CD8–CD25+ T cells in ABX-treated 





Figure 9. No changes of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in 
chicken splenocytes treated with antibiotics. Spleens were taken from two 
week-old chickens and splenocytes were treated with pre-determined 
concentration of each antibiotic or mixed antibiotics (ABX). (A) Cell number 
and (B) proportion of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells were 
examined using anti-chicken CD4-FITC, CD8a-PE and CD25-Alexa647 
antibodies by flow cytometry. Con, non-treatment; A, ampicillin (100 g/ml); 
G, gentamycin (100 g/ml); M, metronidazole (100 g/ml); N, neomycin (100 
g/ml); V; vancomycin (50 g/ml); and ABX, antibiotics cocktail as mentioned 




7) Changes of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in 
periphery of ABX-treated chickens 
 
I further examined the reduction of CD4+CD8–CD25+ and CD4+CD8+CD25+ 
T cells in periphery organs in ABX-treated chickens. It has been suggested that 
CD5hiCD4+CD25–Foxp3– T cells preferentially develop into peripheral Foxp3+ 
Tregs in mice [109]. The present results showed that CD5hi cells were deceased 
in both CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in cecal tonsils of 
ABX-treated chickens (Fig. 10).  
CD4+CD25+ T cells migrate from thymus to cecal tonsils preferentially [110]. 
The reduction of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in cecal 
tonsils could be resulted by lesser migration from thymus. The results showed 
that CD4+CD8+ T cells are the major population of CD4+ T cells in chicken 
thymus (Fig. 11A). Furthermore, there was no change on CD5 expression 
onCD4+CD8+CD25+ T cells in the thymus from ABX-treated chickens (Fig. 
11B). Taken together, the reduction of CD4+CD8–CD25+ and CD4+CD8+CD25+ 





Figure 10. Reduction of CD5hi cells in CD4+CD8–CD25+ and 
CD4+CD8+CD25+ T cells in ABX-treated chickens. Chickens, at hatching, 
were given water containing antibiotics for 7 days and cecal tonsils were taken. 
Single cells from cecal tonsils were, then, stained with anti-chicken CD4, CD5, 
CD8, and CD25 antibodies. (A) The percentage of CD5hi and CD5low/– cells 
was analyzed in CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in cecal 
tonsils by using flow cytometry. (B) CD5hi and CD5low/- cells in CD4+CD8– and 
CD4+CD8+CD25+ T cells were evaluated by Grandparents analysis by using 
FlowJo. Significant differences were shown as asterisks between Con and ABX 





Figure 11. CD5hi cells of CD4+CD8+CD25+ T cells were not changed in 
thymus of ABX-treated chickens. Chickens at hatching were given water 
containing antibiotics for 7 days and thymus was taken. Single cells from 
thymus were, then, stained with anti-chicken CD4, CD8, and CD25 antibodies. 
(A) Thymocytes were analyzed by dot plot based on CD4 and CD8 expression. 
(B) Total cell number was obtained from a thymic lobe. Cell number of (C) 
CD4+CD8+CD25+ T cells and (D) CD5hi of CD4+CD8+CD25+ T cells, and the 
percentage of (E) CD4+CD8+CD25+ T cells and (F) CD5hi of CD4+CD8+CD25+ 




8) Suppressive function of CD4+CD8–CD25+ and 
CD4+CD8+CD25+ T cells in ABX-treated chickens 
 
The elimination of gut microbiota caused reduction of IL-10 mRNA in 
CD4+CD8–CD25+ T cells (Fig. 8A). It could be postulated that the reduction of 
IL-10 expression caused to change the function of CD4+CD8–CD25+ T cells 
since it is known as an immune suppressive cytokine [111]. I examined whether 
the elimination of gut microbiota affected the suppressive function of 
CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells. CD4+CD8–CD25– and 
CD4+CD8+CD25– T cells from ABX-treated chickens were proliferated more 
than those of Con (Fig. 12) suggesting that the elimination of gut microbiota 
caused a significant reduction of CD4+CD8–CD25– and CD4+CD8+CD25– T 




Figure 12. Elimination of gut microbiota caused reduction of suppressive 
ability of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells. Spleens were 
taken from two week-old chickens administered with water (Con) or water 
containing antibiotics (ABX) for two weeks. Splenic CD4+ T cells were sorted 
by magnetic bead sorting. CD4+ T cells, stained with CellTrace™ Violet (CTV) 
dye, were stimulated with anti-chicken CD3 and CD28 antibodies for 3 d. 
Proliferation of CD4+CD8–CD25– and CD4+CD8+CD25– T cells were 
determined by flow cytometry. Significant differences were shown as an 






9) Changes of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in 
ABX-treated chickens after co-housing with control chickens 
 
CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells were significantly reduced 
in ABX-treated chickens (Fig. 6). Therefore, the reconstitution of gut 
microbiota may concordant with recovery of CD4+CD8–CD25+ and 
CD4+CD8+CD25+ T cells in ABX-treated chickens was examined after co-
housing with wild type chickens. The CFU was observed as early as 6 h post 
co-housing and reached at the similar level as ABX-untreated control at 1 d 
post co-housing (Fig. 13A). Interestingly, the number of CD4+CD8–CD25+ and 
CD4+CD8+CD25+ T cells was gradually increased to the similar level as control 
at 7 days post co-housing (Fig. 13B) suggesting that gut microbiota influence 





Figure 13. Changes of CFU, and CD4+CD8–CD25+ and CD4+CD8+CD25+ 
T cells in cecal tonsils from ABX-treated chickens after co-housing with 
control chickens. Chickens at hatching were treated with ABX for 7 days and 
then co-housed with ABX-untreated control (Con) chickens for 7 days at the 
normal condition. (A) CFU was measured from cecal contents (1 mg/ml) at 6 
h, 1 d, 3 d and 5 d after co-housing. (B) Proportion and cell number of 
CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in cecal tonsils were analyzed 
by flow cytometry after co-housing for 1 d, 3 d and 7 days. Significant 





10) Effect of Gram-positive or negative bacteria on the population 
changes of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells 
 
  Next, I examined whether Gram-positive or Gram-negative bacteria 
influenced the change of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells. 
Selective deletion of bacteria by using vancomycin (Van) for eliminating Gram-
positive bacteria and polymyxin B (PolyB) for Gram-negative bacteria [2], was 
performed. The total CFU of Van and PolyB was slightly higher than that of 
Con (Fig. 14A). PolyB eliminated Gram-negative bacteria completely. Van 
eliminated Gram-positive bacteria from 33% to 7% (Fig. 14B). Surprisingly, 
CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells were significantly decreased 
by Van, but not PolyB treatment (Fig. 14C). In order to make sure the effect of 
Van, I have examined another group, ABX without vancomycin, Without Van, 
and the result showed no significant differences (Fig. 14D) indicating the 
change was caused by Gram-positive bacteria. Taken together, Gram-positive 






Figure 14. Elimination of Gram positive bacteria is responsible for the 
change of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in ABX-treated 
chickens. Chickens, at hatching, were treated with vancomycin (Van; 50 mg/ml), 
antibiotics without vancomycin (Without van; ampicillin 100 mg/ml, 
gentamycin 100 mg/ml, metronidazole 100 mg/ml, neomycin 100 mg/ml), or 
polymyxin B (PolyB; 10 mg/ml) for 7 days and co-housed with ABX-untreated 
control (Con) chickens for 7 days. (A) CFU of cecal contents was measured 
from Van and PolyB groups and, (B) The composition of colonies was averaged 
with Gram positive or negative colonies pre-determined by Gram staining. (C 
and D) Proportion of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in cecal 
tonsils were analyzed in chickens treated with vancomycin (Van), polymyxin B 
(PolyB), or antibiotics without vancomycin (Without Van) using flow 
cytometry and FlowJo. Significant differences were shown as a different 
alphabet at P ≤ 0.05.  
49 
 
11) Effect of SCFAs on CD4+CD8–CD25+ and CD4+CD8+CD25+ T 
cells 
 
It has been suggested that short SCFAs are one of the factors to induce Tregs 
or Tr1 in mice [91]. We, therefore, examined whether SCFAs affect the 
population of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in chickens. It 
was intriguing that ABX-treated chickens administered with acetate recovered 
CD4+CD8–CD25+ T cells in cecal tonsils (Fig. 15A). CD4+CD8+CD25+ T cells 
showed a tendency of recovery without significant (Fig. 15B). Other SCFAs, 
butyrate and propionate, did not show such effect (Fig. 15C-F). GPR43 is 
known as a receptor for acetate [112]. GPR43 mRNA expression on CD4+CD8–
CD25+ T cells was significantly higher than other immune cells (Fig. 15G) 
strongly suggest that the recovery of CD4+CD8–CD25+ T cells by acetate 
administration in ABX-treated chickens could be associated with high GPR43 





Figure 15. Changes of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in 
chickens administered with acetate. SCFAs (acetate 50 mM, butyrate 30 mM, 
propionate 10 mM) or ABX was treated to chickens at hatching with drinking 
water for 7 days. Cell number of (A, C and E) CD4+CD8–CD25+ and (B, D and 
F) CD4+CD8+CD25+ T cells of cecal tonsils was calculated with total cell 
number and proportion of CD4+ subtype T cells. (G) Each subset of CD4+ T 
cells, B cells (Bu-1+) and APCs (KUL01+, MHC class II (MHC2)+KUL01–Bu-
1–) were sorted by using ARIA II FACS sorter. The mRNA was extracted from 
each subset and the level of GPR43 was determined by RT-qPCR. Significant 






The purpose of the present study was to reveal the relationship gut 
microbiota and homeostasis in chicken. Chicken model was established to 
remove gut microbiota by antibiotics, as ABX-treated chickens. I demonstrated 
that proportion and absolute number of CD4+CD8–CD25+ and 
CD4+CD8+CD25+ T cells were significantly diminished in cecal tonsils of 
chickens after the elimination of gut microbiota. It was noting that there was no 
change on the CD4+CD8+CD25+ T cells in thymus. Expression of IL-10 and 
IFN-, and suppressive function of CD4+CD8–CD25+ and CD4+CD8+CD25+ T 
cells were significantly decreased by the elimination of gut microbiota. Gram 
positive bacteria appeared to be responsible for the recovery of CD4+CD8–
CD25+ and CD4+CD8+CD25+ T cells. Furthermore, CD4+CD8–CD25+ T cells 
were induced by acetate administration. GPR43 was highly expressed on 
CD4+CD8–CD25+ T cells. 
I showed the inhibitory activity of CD4+CD8–CD25+ and CD4+CD8+CD25+ 
T cells in cecal tonsils from ABX-treated chickens. I postulated that CD4+CD8–
CD25+ and CD4+CD8+CD25+ T cells may resemble Tr1 cells, because Tr1 cells 
are known as non-Foxp3 Tregs in human and mouse [8], and there is no Foxp3 
gene in chicken [11]. Furthermore, CD4+CD8–CD25+ T cells expressed IL-10 
and IFN-(Fig. 7). Indeed, it has been demonstrated that Tr1 cells produce IL-
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10 and IFN- much more than Foxp+ Tregs in mouse [113]. I examined 
transcription factors associated Tr1 cells, namely cellular homolog of the avian 
virus oncogene musculoaponeurotic fibrosarcoma (c-Maf) and aryl 
hydrocarbon receptor (Ahr) [87]. There are homolog genes of c-Maf and AhR 
in chicken that are Gallus gallus v-maf avian musculoaponeurotic fibrosarcoma 
oncogene homolog (Maf) and Gallus gallus aryl hydrocarbon receptor (Ahr). 
There were no differences of Maf and Ahr mRNA level among CD4+ subtype 
T cells (Suppl. Fig. 1). It has been suggested that the kinetics of both Maf and 
Ahr were increased coincident with Tr1 induction, TGF- and IL-27 [114]. 
Molecular mechanisms of Maf and Ahr in CD4+CD8–CD25+ and 
CD4+CD8+CD25+ T cells should be further investigated in chicken.  
 
 
Supplementary Figure 1. No differences in Maf and Ahr gene expression 
levels among CD4+ subtype T cells. Chickens at hatching were given water 
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containing antibiotics for 7 days and cecal tonsils were taken. Single cells from 
cecal tonsils were, then, stained with anti-chicken CD4, CD8a, and CD25 
antibodies. Each subset of CD4+ T cells was sorted by using ARIA II FACS 
sorter. The mRNA was extracted from each subset and the level of (A) Maf and 
(B) Ahr was determined by RT-qPCR.  
 
There are a very few, if any, studies on the function of CD4+CD8+ T cells in 
chicken. Peripheral CD4+CD8+ T cells, analyzed in current study, are referred 
as CD4+CD8a+ (double positive; DP) T cells in human and other chicken 
studies. DP T cells are very small population (< 3%) in blood of health people 
[115]. DP T cells secret IL-2 and IFN- and help the differentiation of B cells 
[116]. DP T cells express CD8lower than CD8+ cytotoxic T cells [117]. 
Interestingly, DP T cells are distributed in intestine abundantly when compared 
with those in blood in human [118, 119]. It has been shown that human 
intestinal DP T cells express IL-10 and IFN-, and no Foxp3 [120]. Human 
intestinal DP T cells are known to suppress proliferation of CD4+ T cells [120]. 
In the lamina propria of IBD patients, DP T cells are significantly decreased 
[120]. The intestinal DP T cells expressed IL-10 or IFN-specifically when 
they were stimulated with Faecalibacterium prausnitzii, a Clostridium cluster 
IV strain [120]. In mice, DP intraepithelial lymphocytes (IELs) are known to 
produce IL-10 and prevent Type 1 helper T (Th1) cell-induced intestinal 
inflammation in a GATA3-dependent manner [120]. In chicken, DP T cells are 
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observed in the peripheral blood (20-40%), spleen (10-20%) and intestinal 
epithelium (5-10%) [121], whereas the function of DP T cells have not been 
studied in detail yet.  
Reduction of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in cecal tonsil 
of ABX-treated chickens could be affected by low level of acetate. In mouse 
studies, induction and function of Tregs are affected by SCFAs [89-91] 
including acetate, propionate, and butyrate [122], which are generated 
especially by Firmicutes and Bacteroidetes, after fermenting undigested 
carbohydrates [84]. Activation of GPR43 using SCFAs promotes the number 
and function of IL-10+Foxp3+ Tregs, and propionate directly increases Foxp3 
expression and IL-10 production [91].  
Both butyrate and propionate are known to induce the differentiation of 
Foxp3+ Tregs [91]. Interestingly, only acetate, not propionate and butyrate, 
induced CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in cecal tonsils. There 
are a few probable reasons for this. Firstly, propionate induced colonic Foxp3+ 
Tregs via GPR43 in vivo [91], whereas no evidence has been reported on the 
induction of Tr1 cells. Secondly, butyrate showed the most efficient HDAC 
inhibitor activity and induced Foxp3+ Tregs [89]. It stimulated the secretion of 
IL-10 and RA from DCs and macrophages via GPR109 expressed in DCs and 
macrophages, not in T cells [98], to induce Foxp3+ Tregs and Tr1 cells [123]. 
However, GPR109 gene does not exist in chicken [124]. Taken together, no 
effect of butyrate on CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells could be 
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caused by no GPR109, which is the essential to induce Tregs.   
Acetate can be produced by enteric bacteria and acetogens from H2 and CO2, 
or from formate via the Wood–Ljungdahl pathway [84, 125]. So far, about 
2,000 acetogens have been characterized [126]. Acetate is transported readily 
to blood, whereas most butyrate is utilized by the epithelial cells [100, 127, 
128]. The mouse studies suggested that the action of acetate appeared to 
mediate GPR41 and GPR 43 [129]. It was noting that mice, treated with 
antibiotics for gut microbiota-free condition, administered with acetate 
recovered colonic Tregs [89]. Acetate can induce the differentiation of naïve T 
cells to Tr1 cells directly with GPR43-independent pathway, whereas it 
acetylated p70 S6 kinase and phosphorylated of ribosomal protein S6 (rS6) as 
a HDAC inhibitor activity [100]. On the contrary, other study suggested that 
SCFAs can directly suppress HDAC in a GPR43-dependent manner [91]. 
Besides, the expression of GPR43 on the regulatory function of T cells has been 
controversial [91, 96, 112].  
How CD4+CD8–CD25+ T cells were affected by acetate is unclear. Acetate 
may play as a HDAC inhibitor via GPR43 [91] and activate mTOR-S6K 
signaling [100] to induce CD4+CD8–CD25+ T cells. In human and mouse 
studies, GPR43 was highly expressed on myeloid cells [91], including 
monocytes [130]. Acetate decreased TNF- and IFN- in human monocytes 
stimulated with LPS [131]. However, there is no evidence that monocytes 
treated with acetate result in the induction of Tregs.  
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There are a few studies on the effect of acetate on immune system in chicken. 
In acetylated starch feeding chickens, lesion score of necrotic enteritis and the 
number of Clostridium perfringens showed no differences compared with those 
of infected only control. Body weight of chicks infected with Clostridium 
perfringens and fed acetylated starch was significantly higher than infected 
chickens [132].  
The other possibility for the reduction of CD4+CD8–CD25+ and 
CD4+CD8+CD25+ T cells in ABX-treated chickens might be reduced migration 
of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in ABX-treated chickens. 
CD4+CD25+ T cells are shown to preferentially migrate to cecal tonsils [110]. I 
confirmed that there was no changes on CD4+CD8+CD25+ T cells in thymus 
and CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells in spleen. Collectively, 
migration is unlikely the mechanism for the reduction of cells CD4+CD8–
CD25+ and CD4+CD8+CD25+ T cells in ABX-treated chickens.  
The present study demonstrated that CD4+CD8–CD25+ and 
CD4+CD8+CD25+ T cells were affected by Gram positive bacteria. Probiotics 
Bifidobacterium breve and B. longum induced colonic Tr1 via CD103+ DCs, 
and Tr1 cells ameliorated severe intestinal inflammation [9]. Clostridium 
cluster IV and XIVa produced abundant acetate as well as lesser butyrate [7]. 
Bifidobacterium and Clostridium as Gram positive bacteria likely affect 
CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells. 
Reduction of Tregs causes susceptible status to induce inflammation in gut. 
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Pathogenic Th17 cells, which are producing IFN- and may cause gut 
inflammation, such as, colitis [133-135]. Tregs could prevent colitis by 
pathogenic Th17 cells [136]. Furthermore, gut inflammation was alleviated by 
generation of Tr1 cells in SCID gut inflammation model, which did not contain 
Tregs [9]. 
In germ-free mouse model, B cells showed a various changes in an organ-
dependent manner. Although germinal center (GC) B cells and IgM+ B cells in 
mesenteric lymph nodes were increased, no differences were found in spleen 
[137]. Furthermore, B cells in bone marrow were increased in germ-free mice 
[138]. The results in the present study showed that there was no change on the 
population of B cells (Bu-1+ cells) in cecal tonsils and spleen of ABX-treated 
chickens. Furthermore, B cells in the bursa of Fabricius were decreased in 
ABX-treated chickens [139]. Chrząstek et al. reported that oral treatment of 
antibiotics to neonatal chickens decreased bursal B cells [140]. But there was 
no explanation at molecular mechanism. 
Macrophages in ABX-treated chickens were not significantly changed in the 
present study. Similarly, macrophages in small intestinal lamina propria [141] 
and colon were not changed in germ-free mice [142]. In other study, 
macrophages were significantly reduced in germ-free mice [143]. No 
population changes on macrophages in cecal tonsils from ABX-treated 
chickens could be caused by sustaining recruitment of monocytes. 
I established ABX-treated chicken model by removal of gut microbiota to 
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study gut homeostasis. It was noting that the ABX-treated chickens showed no 
changes on physiological traits including body weight, length of intestine, 
weight of a major organs, and glucocorticoid level in serum. In the present study, 
antibiotics was diluted 10-times more [108] and treated shorter time [2, 89] than 
those studies using ABX-treated mice [144-146]. The reasons could be that (1) 
born-free of microbes in chicks by the time of hatching [147], (2) unlike 
mammal, no interference of microbiota from the mother [148], (3) simple and 
easy control of microbiota at the initial stage as to provide a water containing 
ABX [147], (4) social differences in mouse including coprophagy and bruxing 
[149].  
Antibiotics seemingly affect not only the population of microbiota but also 
a metabolism in the host. Although precise action mode of antibiotics for 
promoting growth in domestic animals is still unclear, it is widely accepted that 
antibiotics modulate gut microbiome and their products, such as short chain 
fatty acids [150] causing changes on the magnitude of host immunity. Of course, 
the suppression of enteric pathogens, for instance, Escherichia coli, Salmonella 
ssp., and Clostridium perfringens, by antibiotics would be a benefit for healthy 
intestinal epithelium [151]. However, how antibiotics target specifically those 
enteric pathogens, not common microbes, is yet to be defined and difficult to 
explain. Besides the dose of antibiotics used in the domestic animal feed 
industry was known to be a sub-therapeutic dose [152, 153]. It is likely that 
antibiotics, especially at the level used as a feed additive, would have 
59 
 
modulated host cells including primarily epithelial cells and intestinal immune 
cells.  
Collectively, my study suggests that gut microbiota regulate both the 
population and the function of CD4+CD8–CD25+ and CD4+CD8+CD25+ T cells 
in cecal tonsils, and acetate plays as an important factor for gut immune 
homeostasis. It is likely that acetate producing Gram-positive bacteria can be 
applied to improve the gut health and used as probiotics. Furthermore, ABX-
treated chicken model could be used for future studies on the relationship 
between gut homeostasis and microbes, including probiotics and synbiotics.  
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VII. Summary in Korean 
 
닭에서 장내 미생물 연구의 대부분은 성장 촉진 분야이며 장 
항상성 관련 연구는 크게 조명 받지 못한 상태이다. 조절 T 세포는 
CD4+ T 세포의 한 종류로서 장 항상성 유지에 매우 중요한 역할을 
한다고 알려져 있다. 장내 조절 T 세포는 Clostridium spp. cluster IV 
와 XIVa strains, altered Schaedler flora, Bacteroides fragilis 같은 장내 미
생물에 의해 유도 된다. 그러나 닭의 조절 T 세포(CD4+CD25+ T 세
포) 가 장내 미생물과 어떤 연관이 있는지는 거의 알려져 있지 않다. 
본 연구에서는 닭 조절 T 세포와 장내미생물 간 관련성을 밝히
기 위해서 다양한 농도의 항생제(ampicillin, gentamycin, neomycin, 
metronidazole, vancomycin) 조합하여 장내 미생물 제거 하였다. 특정 
농도의 항생제 칵테일(ABX; ampicillin, gentamycin, neomycin, 
metronidazole 100 g/ml 와 vancomycin 50 g/ml)을 7일 간 음수처리 
하였을 때, 맹장 내용물의 박테리아 colony forming unit (CFU)가 99% 
이상 제거되었다. 이때 몸무게, 면역 장기(비장, 활액낭[bursa], 간) 
무게 및 장 (십이지장, 공장, 회장, 대장) 길이에 변화는 없었다. 혈
중 스트레스 호르몬[glucocorticoid] 수치도 변화 없었다. 나아가 비장 
및 맹장 편도의 B 세포 및 대식세포의 비율과 MHC class II 발현 수
치도 변하지 않았다. 이를 바탕으로 장내 미생물이 제거 된 ABX 처
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리 닭 모델을 구축하였다. 
다음으로 장내 미생물이 제거 되었을 때, CD4+ T 세포 변화를 
살펴보았다. ABX 처리 닭 모델의 맹장 편도 CD4+CD8–CD25+ T 세포 
및 CD4+CD8+CD25+ T 세포 비율과 세포수가 유의적으로 감소하였다. 
그러나 비장 CD4+CD8–CD25+ T 세포 및 CD4+CD8+CD25+ T 세포는 
변하지 않았다. 사이토카인 발현 변화를 보았을 때, ABX 처리 닭 모
델 유래 CD4+CD8–CD25+ T 세포 및 CD4+CD+CD25+ T 세포에서 IL-10 
과 IFN-mRNA 발현이 유의적으로 감소하였다. 나아가 ABX 처리 
닭 모델 유래 CD4+CD8–CD25+ T 세포 및 CD4+CD8+CD25+ T 세포의 
CD4+CD25– T 세포 증식 억제능이 유의적으로 감소하였다. 마우스 
연구에서는 CD5hi CD4+Foxp3– T 세포가 말단 조절 T 세포로 분화된
다고 잘 알려져 있다. 이를 ABX 처리 닭 모델에서 확인해본 결과, 
감소된 CD4+CD8–CD25+ T 세포 및 CD4+CD8+CD25+ T 세포는 대부분 
CD5hi 세포였으며, 흉선 CD4+CD8+CD25+ T 세포는 변하지 않았다. 종
합하면 장내 미생물이 제거 되면서 맹장 편도 CD4+CD8–CD25+ T 세
포 및 CD4+CD8+CD25+ T 세포도 감소되었으며, 억제능 또한 감소되
었다.  
다음으로 CD4+CD8–CD25+ T 세포 및 CD4+CD8+CD25+ T 세포 감
소가 어떤 요인에 의해 발생된 것인지 확인하였다. 먼저, 장내 미생
물이 회복 되었을 때, CD4+CD8–CD25+ T 세포 및 CD4+CD8+CD25+ T 
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세포가 회복하는지 확인하기 위해, ABX 처리 닭 모델을 일반 닭과 
공동 사육하였다. 그 결과, 공동 사육 5일째, ABX 처리 닭 모델의 
CFU 가 일반 닭과 비슷한 수준으로 회복하였으며, 7일 째, CD4+CD8–
CD25+ T 세포 및 CD4+CD8+CD25+ T 세포가 회복되는 것을 확인하였
다. 나아가 그람 양성균을 특이적으로 제거하는 항생제(vancomycin)
와 그람 음성균을 특이적 제거하는 항생제(polymyxin B)를 음수 처리 
하는 실험을 통해 CD4+CD8–CD25+ T 세포 및 CD4+CD8+CD25+ T 세포
는 그람 양성균에 의존적인 것으로 나타났다. 단쇄지방산 중 하나인 
아세테이트를 음수 급이 하였을 때, 장내 미생물이 제거 되었음에도 
불구하고 CD4+CD8–CD25+ T 세포 및 CD4+CD8+CD25+ T 세포가 회복
되었다. 그 외 단쇄지방산 인 뷰틸레이트와 프로피오네이트는 효과
를 보이지 않았다. 나아가 CD4+CD8–CD25+ T 세포에서 아세테이트의 
수용체로 알려진 GPR43 발현이 다른 면역세포와 비교하였을 때, 
mRNA 수준에서 유의적으로 높게 나타났다. 
종합하면, 그람 양성균 의해 CD4+CD8–CD25+ T 세포와 
CD4+CD8+CD25+ T 세포의 군집 및 기능이 조절되며, 특히 CD4+CD8–
CD25+ T 세포는 GPR43 에 매개하여 아세테이트에 의해 유도 되는 
것으로 사료된다.  
 
 
